Halozyme Therapeutics Inc
F:RV7
Halozyme Therapeutics Inc
F:RV7
Price:
53.78
EUR
0.15%
Market Cap:
€6.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
Halozyme Therapeutics Inc
F:RV7
|
US |
|
Sibanye Stillwater Ltd
F:47V
|
ZA |
|
L
|
Legrand SA
DUS:LRC
|
FR |
|
A
|
ASR Nederland NV
SWB:A16
|
NL |
|
C
|
Chocoladefabriken Lindt & Spruengli AG
SWB:LSPP
|
CH |
|
M
|
Mitsubishi Heavy Industries Ltd
DUS:MIH
|
JP |
|
H
|
Heineken Holding NV
F:4H5
|
NL |
|
P
|
Paccar Inc
SWB:PAE
|
US |
|
E
|
Eastman Chemical Co
F:EAC
|
US |
|
AngloGold Ashanti Ltd
F:AOD1
|
ZA |
|
U
|
United Parcel Service Inc
BMV:UPS
|
US |
|
C4 Therapeutics Inc
NASDAQ:CCCC
|
US |
Multiples-Based Value
The Multiples-Based Value for 
Halozyme Therapeutics Inc (RV7) under the Base Case is hidden
EUR.
Compared with the current market price of 53.78 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RV7 Multiples-Based Value
LOCKED
